Click here to get full coverage on Entrada Therapeutics (TRDA) CFO receives new equity grants and automatic tax share sales - Stock Titan

Entrada Therapeutics (TRDA) CFO receives new equity grants and automatic tax share sales  Stock Titan

Entrada Therapeutics (TRDA) CFO receives new equity grants and automatic tax share sales - Stock Titan

Click here to get full coverage on TRDA: Four clinical readouts and pipeline expansion set up a pivotal 2026, driven by EEV technology - TradingView

TRDA: Four clinical readouts and pipeline expansion set up a pivotal 2026, driven by EEV technology  TradingView

TRDA: Four clinical readouts and pipeline expansion set up a pivotal 2026, driven by EEV technology - TradingView

Click here to get full coverage on Entrada Therapeutics (TRDA) Quarterly Revenue Slump Tests Bullish Growth Narratives - simplywall.st

Entrada Therapeutics (TRDA) Quarterly Revenue Slump Tests Bullish Growth Narratives  simplywall.st

Entrada Therapeutics (TRDA) Quarterly Revenue Slump Tests Bullish Growth Narratives - simplywall.st

Click here to get full coverage on The Technical Signals Behind (TRDA) That Institutions Follow - Stock Traders Daily

The Technical Signals Behind (TRDA) That Institutions Follow  Stock Traders Daily

The Technical Signals Behind (TRDA) That Institutions Follow - Stock Traders Daily

Click here to get full coverage on Entrada Therapeutics (NASDAQ:TRDA) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Entrada Therapeutics (NASDAQ:TRDA) Stock Rating Upgraded by Wall Street Zen  MarketBeat

Entrada Therapeutics (NASDAQ:TRDA) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Click here to get full coverage on Entrada Therapeutics (TRDA) CEO gets RSUs, options and tax-related share sales - Stock Titan

Entrada Therapeutics (TRDA) CEO gets RSUs, options and tax-related share sales  Stock Titan

Entrada Therapeutics (TRDA) CEO gets RSUs, options and tax-related share sales - Stock Titan

Click here to get full coverage on TRDA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

TRDA Stock News Today | Earnings, Events & Price Alerts  Intellectia AI

TRDA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Click here to get full coverage on Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline - Yahoo Finance

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline  Yahoo Finance

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline - Yahoo Finance

Click here to get full coverage on New Analyst Forecast: $TRDA Given $20 Price Target - Quiver Quantitative

New Analyst Forecast: $TRDA Given $20 Price Target  Quiver Quantitative

New Analyst Forecast: $TRDA Given $20 Price Target - Quiver Quantitative

Click here to get full coverage on Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring A 54% Potential Upside - DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring A 54% Potential Upside  DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring A 54% Potential Upside - DirectorsTalk Interviews

Click here to get full coverage on Earnings Summary: Entrada Therapeutics Q4 - Benzinga

Earnings Summary: Entrada Therapeutics Q4  Benzinga

Earnings Summary: Entrada Therapeutics Q4 - Benzinga

Click here to get full coverage on Oppenheimer Maintains Entrada Therapeutics(TRDA.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛

Oppenheimer Maintains Entrada Therapeutics(TRDA.US) With Buy Rating, Maintains Target Price $21  富途牛牛

Oppenheimer Maintains Entrada Therapeutics(TRDA.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛

Click here to get full coverage on Entrada Therapeutics (TRDA) COO logs new RSU, option grants and tax share disposals - Stock Titan

Entrada Therapeutics (TRDA) COO logs new RSU, option grants and tax share disposals  Stock Titan

Entrada Therapeutics (TRDA) COO logs new RSU, option grants and tax share disposals - Stock Titan

Click here to get full coverage on Entrada Therapeutics (NASDAQ:TRDA) Posts Earnings Results, Beats Estimates By $0.38 EPS - MarketBeat

Entrada Therapeutics (NASDAQ:TRDA) Posts Earnings Results, Beats Estimates By $0.38 EPS  MarketBeat

Entrada Therapeutics (NASDAQ:TRDA) Posts Earnings Results, Beats Estimates By $0.38 EPS - MarketBeat

Click here to get full coverage on Entrada Therapeutics (TRDA) grants RSUs and options as automatic share sales cover taxes - Stock Titan

Entrada Therapeutics (TRDA) grants RSUs and options as automatic share sales cover taxes  Stock Titan

Entrada Therapeutics (TRDA) grants RSUs and options as automatic share sales cover taxes - Stock Titan

Click here to get full coverage on Entrada hands new hires 12,990 stock units tied to Nasdaq rule - Stock Titan

Entrada hands new hires 12,990 stock units tied to Nasdaq rule  Stock Titan

Entrada hands new hires 12,990 stock units tied to Nasdaq rule - Stock Titan

Click here to get full coverage on Entrada Therapeutics (NASDAQ: TRDA) maps DMD, DM1 and ocular drug pipeline - Stock Titan

Entrada Therapeutics (NASDAQ: TRDA) maps DMD, DM1 and ocular drug pipeline  Stock Titan

Entrada Therapeutics (NASDAQ: TRDA) maps DMD, DM1 and ocular drug pipeline - Stock Titan

Click here to get full coverage on Entrada Therapeutics (TRDA) swings to 2025 loss while advancing DMD pipeline - Stock Titan

Entrada Therapeutics (TRDA) swings to 2025 loss while advancing DMD pipeline  Stock Titan

Entrada Therapeutics (TRDA) swings to 2025 loss while advancing DMD pipeline - Stock Titan

Click here to get full coverage on DMD trials advance as Entrada extends cash runway to Q3 2027 - Stock Titan

DMD trials advance as Entrada extends cash runway to Q3 2027  Stock Titan

DMD trials advance as Entrada extends cash runway to Q3 2027 - Stock Titan

Click here to get full coverage on Duchenne drug trial doubles dose to 12 mg/kg, aims at accelerated FDA approval - Stock Titan

Duchenne drug trial doubles dose to 12 mg/kg, aims at accelerated FDA approval  Stock Titan

Duchenne drug trial doubles dose to 12 mg/kg, aims at accelerated FDA approval - Stock Titan

Click here to get full coverage on Entrada Therapeutics (TRDA) to Release Earnings on Thursday - MarketBeat

Entrada Therapeutics (TRDA) to Release Earnings on Thursday  MarketBeat

Entrada Therapeutics (TRDA) to Release Earnings on Thursday - MarketBeat

Click here to get full coverage on Earnings Summary: Entrada Therapeutics Q4 - Sahm

Earnings Summary: Entrada Therapeutics Q4  Sahm

Earnings Summary: Entrada Therapeutics Q4 - Sahm

Click here to get full coverage on Entrada Therapeutics (NASDAQ:TRDA) Given Buy Rating at HC Wainwright - MarketBeat

Entrada Therapeutics (NASDAQ:TRDA) Given Buy Rating at HC Wainwright  MarketBeat

Entrada Therapeutics (NASDAQ:TRDA) Given Buy Rating at HC Wainwright - MarketBeat

Click here to get full coverage on Entrada Therapeutics Q4 net loss and EPS beat expectations - TradingView

Entrada Therapeutics Q4 net loss and EPS beat expectations  TradingView

Entrada Therapeutics Q4 net loss and EPS beat expectations - TradingView

Click here to get full coverage on Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Potential Upside of 67.57% Could Attract Investors - DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Potential Upside of 67.57% Could Attract Investors  DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Potential Upside of 67.57% Could Attract Investors - DirectorsTalk Interviews

Click here to get full coverage on Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Bitget

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  Bitget

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Bitget

Click here to get full coverage on Entrada Therapeutics, Inc. SEC 10-K Report - TradingView

Entrada Therapeutics, Inc. SEC 10-K Report  TradingView

Entrada Therapeutics, Inc. SEC 10-K Report - TradingView

Click here to get full coverage on Entrada Therapeutics, Inc. (NASDAQ:TRDA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - simplywall.st

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report  simplywall.st

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - simplywall.st

Click here to get full coverage on Entrada Therapeutics, Inc. (TRDA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Entrada Therapeutics, Inc. (TRDA) Reports Q3 Loss, Misses Revenue Estimates  Yahoo Finance

Entrada Therapeutics, Inc. (TRDA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Click here to get full coverage on Entrada Therapeutics: Soft Q3 Earnings, But Builds Momentum Toward 2026 Readouts - Seeking Alpha

Entrada Therapeutics: Soft Q3 Earnings, But Builds Momentum Toward 2026 Readouts  Seeking Alpha

Entrada Therapeutics: Soft Q3 Earnings, But Builds Momentum Toward 2026 Readouts - Seeking Alpha

Click here to get full coverage on $TRDA stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

$TRDA stock is up 8% today. Here's what we see in our data.  Quiver Quantitative

$TRDA stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring A 105.99% Potential Upside - DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring A 105.99% Potential Upside  DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring A 105.99% Potential Upside - DirectorsTalk Interviews

Click here to get full coverage on Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Promising 66% Upside Potential In Biotech Innovation - DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Promising 66% Upside Potential In Biotech Innovation  DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Promising 66% Upside Potential In Biotech Innovation - DirectorsTalk Interviews

Click here to get full coverage on Tennessee Rental Dealers Honor RTO Trio At Membership Meeting - rtohq.org

Tennessee Rental Dealers Honor RTO Trio At Membership Meeting  rtohq.org

Tennessee Rental Dealers Honor RTO Trio At Membership Meeting - rtohq.org

Click here to get full coverage on Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring The 166.57% Potential Upside - DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring The 166.57% Potential Upside  DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring The 166.57% Potential Upside - DirectorsTalk Interviews

Click here to get full coverage on New RNA-based drugs advance for muscular dystrophy and inherited blindness - Stock Titan

New RNA-based drugs advance for muscular dystrophy and inherited blindness  Stock Titan

New RNA-based drugs advance for muscular dystrophy and inherited blindness - Stock Titan

Click here to get full coverage on 2025 Tennessee Rental Dealers Association (TRDA) Annual Meeting - rtohq.org

2025 Tennessee Rental Dealers Association (TRDA) Annual Meeting  rtohq.org

2025 Tennessee Rental Dealers Association (TRDA) Annual Meeting - rtohq.org

Click here to get full coverage on Entrada Therapeutics, Inc. (TRDA) Stock Analysis: A 55.81% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: A 55.81% Potential Upside in the Biotech Sector  DirectorsTalk Interviews

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: A 55.81% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Click here to get full coverage on Revenues Working Against Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Share Price - 富途牛牛

Revenues Working Against Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Share Price  富途牛牛

Revenues Working Against Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Share Price - 富途牛牛

Click here to get full coverage on Entrada Therapeutics Awards Nearly 24,000 RSUs in Latest Employee Compensation Plan - Stock Titan

Entrada Therapeutics Awards Nearly 24,000 RSUs in Latest Employee Compensation Plan  Stock Titan

Entrada Therapeutics Awards Nearly 24,000 RSUs in Latest Employee Compensation Plan - Stock Titan

Click here to get full coverage on TRDA Winners Celebration 2025 - Graduate Studies - Trinity College Dublin

TRDA Winners Celebration 2025 - Graduate Studies  Trinity College Dublin

TRDA Winners Celebration 2025 - Graduate Studies - Trinity College Dublin

Click here to get full coverage on Entrada Therapeutics Eyes 2026 Trial Data With Cash Runway Into 2027 - RTTNews

Entrada Therapeutics Eyes 2026 Trial Data With Cash Runway Into 2027  RTTNews

Entrada Therapeutics Eyes 2026 Trial Data With Cash Runway Into 2027 - RTTNews

Click here to get full coverage on Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates - Investing.com Canada

Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates  Investing.com Canada

Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates - Investing.com Canada

Click here to get full coverage on Postgraduate Teaching Awards - Trinity College Dublin

Postgraduate Teaching Awards  Trinity College Dublin

Postgraduate Teaching Awards - Trinity College Dublin

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Entrada Therapeutics, Inc. (TRDA) Live Share Price, Invest From India - INDmoney

Entrada Therapeutics, Inc. (TRDA) Live Share Price, Invest From India  INDmoney

Entrada Therapeutics, Inc. (TRDA) Live Share Price, Invest From India - INDmoney

Click here to get full coverage on IRS Establishes New Voluntary Tip Reporting Program - Tax Notes

IRS Establishes New Voluntary Tip Reporting Program  Tax Notes

IRS Establishes New Voluntary Tip Reporting Program - Tax Notes

Click here to get full coverage on Poco F8 Pro appears together with Redmi Note 15 Pro 4G in TRDA - Gizmochina

Poco F8 Pro appears together with Redmi Note 15 Pro 4G in TRDA  Gizmochina

Poco F8 Pro appears together with Redmi Note 15 Pro 4G in TRDA - Gizmochina

Click here to get full coverage on Vivo V60 India Launch Teased; Reportedly Spotted on TRDA Certification Site - Gadgets 360

Vivo V60 India Launch Teased; Reportedly Spotted on TRDA Certification Site  Gadgets 360

Vivo V60 India Launch Teased; Reportedly Spotted on TRDA Certification Site - Gadgets 360

Click here to get full coverage on What is the current Price Target and Forecast for Entrada Therapeutics (TRDA) - Zacks Investment Research

What is the current Price Target and Forecast for Entrada Therapeutics (TRDA)  Zacks Investment Research

What is the current Price Target and Forecast for Entrada Therapeutics (TRDA) - Zacks Investment Research

Click here to get full coverage on Technical Analysis of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - TradingView

Technical Analysis of Entrada Therapeutics, Inc. (NASDAQ:TRDA)  TradingView

Technical Analysis of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - TradingView

Click here to get full coverage on Entrada Therapeutics (TRDA) - Zacks Investment Research

Entrada Therapeutics (TRDA)  Zacks Investment Research

Entrada Therapeutics (TRDA) - Zacks Investment Research

Click here to get full coverage on IRS Releases Revised TRDA for Food and Beverage Industry - Tax Notes

IRS Releases Revised TRDA for Food and Beverage Industry  Tax Notes

IRS Releases Revised TRDA for Food and Beverage Industry - Tax Notes

Click here to get full coverage on TRDA - Entrada Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

TRDA - Entrada Therapeutics, Inc. Latest Stock News & Market Updates  Stock Titan

TRDA - Entrada Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on Entrada (TRDA) Down on FDA Maintaining Clinical Hold on DMD Drug - Yahoo Finance

Entrada (TRDA) Down on FDA Maintaining Clinical Hold on DMD Drug  Yahoo Finance

Entrada (TRDA) Down on FDA Maintaining Clinical Hold on DMD Drug - Yahoo Finance

Click here to get full coverage on Entrada Therapeutics Stock Price Forecast. Should You Buy TRDA? - StockInvest.us

Entrada Therapeutics Stock Price Forecast. Should You Buy TRDA?  StockInvest.us

Entrada Therapeutics Stock Price Forecast. Should You Buy TRDA? - StockInvest.us

Click here to get full coverage on Entrada Therapeutics: A Complicated Tale (NASDAQ:TRDA) - Seeking Alpha

Entrada Therapeutics: A Complicated Tale (NASDAQ:TRDA)  Seeking Alpha

Entrada Therapeutics: A Complicated Tale (NASDAQ:TRDA) - Seeking Alpha

Click here to get full coverage on Entrada Therapeutics: Early Stage But Interesting (NASDAQ:TRDA) - Seeking Alpha

Entrada Therapeutics: Early Stage But Interesting (NASDAQ:TRDA)  Seeking Alpha

Entrada Therapeutics: Early Stage But Interesting (NASDAQ:TRDA) - Seeking Alpha

Click here to get full coverage on Entrada Therapeutics (TRDA) Stock Price, News & Analysis $TRDA - MarketBeat

Entrada Therapeutics (TRDA) Stock Price, News & Analysis $TRDA  MarketBeat

Entrada Therapeutics (TRDA) Stock Price, News & Analysis $TRDA - MarketBeat

Click here to get full coverage on PI Only Winners 2024 2025 - Graduate Studies - Trinity College Dublin

PI Only Winners 2024 2025 - Graduate Studies  Trinity College Dublin

PI Only Winners 2024 2025 - Graduate Studies - Trinity College Dublin

Click here to get full coverage on PI Only Winners 2023 2024 - Graduate Studies - Trinity College Dublin

PI Only Winners 2023 2024 - Graduate Studies  Trinity College Dublin

PI Only Winners 2023 2024 - Graduate Studies - Trinity College Dublin

Click here to get full coverage on Entrada Therapeutics (TRDA) Earnings Date and Reports 2026 $TRDA - MarketBeat

Entrada Therapeutics (TRDA) Earnings Date and Reports 2026 $TRDA  MarketBeat

Entrada Therapeutics (TRDA) Earnings Date and Reports 2026 $TRDA - MarketBeat

Click here to get full coverage on Council talks TRDA budget, hires admin - Tahlequah Daily Press

Council talks TRDA budget, hires admin  Tahlequah Daily Press

Council talks TRDA budget, hires admin - Tahlequah Daily Press

Click here to get full coverage on TRDA IPO News - Rare disease biotech Entrada Therapeutics files for a $100 million IPO - renaissancecapital.com

TRDA IPO News - Rare disease biotech Entrada Therapeutics files for a $100 million IPO  renaissancecapital.com

TRDA IPO News - Rare disease biotech Entrada Therapeutics files for a $100 million IPO - renaissancecapital.com

Click here to get full coverage on Entrada Therapeutics: Cash-Rich Innovator With Asymmetric Upside - Seeking Alpha

Entrada Therapeutics: Cash-Rich Innovator With Asymmetric Upside  Seeking Alpha

Entrada Therapeutics: Cash-Rich Innovator With Asymmetric Upside - Seeking Alpha

Click here to get full coverage on OPPO Find X5 and Find X5 Pro get certified, here are the camera details - Pocketnow

OPPO Find X5 and Find X5 Pro get certified, here are the camera details  Pocketnow

OPPO Find X5 and Find X5 Pro get certified, here are the camera details - Pocketnow

Click here to get full coverage on Postgraduate Teaching Awards 2024 - Graduate Studies - Trinity College Dublin

Postgraduate Teaching Awards 2024 - Graduate Studies  Trinity College Dublin

TRDA

Price Chart

Key Statistics

Technicals

About TRDA

Latest News

Entrada Therapeutics (TRDA) CFO receives new equity grants and automatic tax share sales - Stock Titan

TRDA: Four clinical readouts and pipeline expansion set up a pivotal 2026, driven by EEV technology - TradingView

Entrada Therapeutics (TRDA) Quarterly Revenue Slump Tests Bullish Growth Narratives - simplywall.st

Advanced Charts

Top Gainers

Top Losers